PNC Financial Services Group’s Mural Oncology MURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-62
Closed -$128 5264
2025
Q3
$128 Hold
62
﹤0.01% 4976
2025
Q2
$154 Hold
62
﹤0.01% 4816
2025
Q1
$78 Hold
62
﹤0.01% 4831
2024
Q4
$200 Hold
62
﹤0.01% 4652
2024
Q3
$194 Sell
62
-5,782
-99% -$18.8K ﹤0.01% 4682
2024
Q2
$18.4K Sell
5,844
-6,320
-52% -$23.3K ﹤0.01% 3525
2024
Q1
$59.5K Sell
12,164
-3,425
-22% -$16.6K ﹤0.01% 2909
2023
Q4
$92.3K Buy
+15,589
New +$62.7K ﹤0.01% 2672

PNC Financial Services Group's MURA Position: Q4 2025 in Review

PNC Financial Services Group sold out of Mural Oncology (MURA) in Q4 2025, closing a stake of 62 shares — an estimated $128 sold.

PNC Financial Services Group first reported a position in MURA in Q4 2023 and held it in 8 quarters. The position peaked at $92.3K in Q4 2023. 0 funds tracked by Wall St. Rank hold MURA as of Q4 2025.

  • PNC Financial Services Group reported no remaining Mural Oncology position as of Q4 2025 after selling out during the quarter.
  • PNC Financial Services Group sold 62 Mural Oncology shares in Q4 2025, an estimated $128.
  • PNC Financial Services Group first reported a position in Mural Oncology in Q4 2023 and held it in 8 quarters.
  • PNC Financial Services Group's Mural Oncology position peaked at $92.3K in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Mural Oncology as of Q4 2025.

Based on PNC Financial Services Group's 13F filing for Q4 2025, filed 6 Feb 2026.